Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98820464 | 9882046 | 4 | F | 20120423 | 20160719 | 20140207 | 20160721 | EXP | PHEH2012US008648 | NOVARTIS | 58.99 | YR | F | Y | 66.40000 | KG | 20160721 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98820464 | 9882046 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | 22527 | .5 | MG | CAPSULE | QD | ||||||
| 98820464 | 9882046 | 2 | C | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | TABLET | QD | |||||
| 98820464 | 9882046 | 3 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | 5 MG, UNK | U | 0 | 5 | MG | TABLET | ||||||
| 98820464 | 9882046 | 4 | C | SULFAMETHOXAZOLE-TRIMETHOPRIM (SMZ) | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | 800 MG-160 MG | U | 0 | 1 | DF | TABLET | ||||||
| 98820464 | 9882046 | 5 | C | AZELASTINE | AZELASTINE | 1 | Unknown | UNK UNK, PRN (EYE DROPS 0.05 %) | U | 0 | OINTMENT | ||||||||
| 98820464 | 9882046 | 6 | C | AZELASTINE | AZELASTINE | 1 | Ophthalmic | UNK | U | 0 | OINTMENT | ||||||||
| 98820464 | 9882046 | 7 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | Oral | 1 DF, TID | U | 0 | 1 | DF | TABLET | TID | |||||
| 98820464 | 9882046 | 8 | C | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | 20 MG, UNK | U | 0 | 20 | MG | |||||||
| 98820464 | 9882046 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 300 MG, UNK | U | 0 | 300 | MG | CAPSULE | ||||||
| 98820464 | 9882046 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 300 MG, 1 IN AM, 1 AT NOON, 2 AT BEDTIME | U | 0 | 300 | MG | CAPSULE | ||||||
| 98820464 | 9882046 | 11 | C | ALEVE | NAPROXEN SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 98820464 | 9882046 | 12 | C | EPITOL | CARBAMAZEPINE | 1 | Unknown | U | 0 | ||||||||||
| 98820464 | 9882046 | 13 | C | NITROFURANTOIN. | NITROFURANTOIN | 1 | Unknown | 100 MG, UNK | U | 0 | 100 | MG | |||||||
| 98820464 | 9882046 | 14 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | U | 0 | ||||||||||
| 98820464 | 9882046 | 15 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | 75 MG, UNK | U | 0 | 75 | MG | |||||||
| 98820464 | 9882046 | 16 | C | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 98820464 | 9882046 | 17 | C | VITAMIN C | ASCORBIC ACID | 1 | Unknown | U | 0 | ||||||||||
| 98820464 | 9882046 | 18 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | U | 0 | ||||||||||
| 98820464 | 9882046 | 19 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | U | 0 | ||||||||||
| 98820464 | 9882046 | 20 | C | TEGRETOL | CARBAMAZEPINE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 98820464 | 9882046 | 1 | Multiple sclerosis |
| 98820464 | 9882046 | 2 | Product used for unknown indication |
| 98820464 | 9882046 | 3 | Product used for unknown indication |
| 98820464 | 9882046 | 4 | Product used for unknown indication |
| 98820464 | 9882046 | 5 | Product used for unknown indication |
| 98820464 | 9882046 | 7 | Product used for unknown indication |
| 98820464 | 9882046 | 8 | Product used for unknown indication |
| 98820464 | 9882046 | 9 | Neuralgia |
| 98820464 | 9882046 | 11 | Product used for unknown indication |
| 98820464 | 9882046 | 12 | Product used for unknown indication |
| 98820464 | 9882046 | 13 | Product used for unknown indication |
| 98820464 | 9882046 | 14 | Product used for unknown indication |
| 98820464 | 9882046 | 15 | Product used for unknown indication |
| 98820464 | 9882046 | 16 | Product used for unknown indication |
| 98820464 | 9882046 | 17 | Product used for unknown indication |
| 98820464 | 9882046 | 18 | Product used for unknown indication |
| 98820464 | 9882046 | 19 | Product used for unknown indication |
| 98820464 | 9882046 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 98820464 | 9882046 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98820464 | 9882046 | Blood pressure increased | |
| 98820464 | 9882046 | Central nervous system lesion | |
| 98820464 | 9882046 | Diplopia | |
| 98820464 | 9882046 | Dizziness | |
| 98820464 | 9882046 | Escherichia urinary tract infection | |
| 98820464 | 9882046 | Hypoaesthesia | |
| 98820464 | 9882046 | Muscular weakness | |
| 98820464 | 9882046 | Nausea | |
| 98820464 | 9882046 | Stress | |
| 98820464 | 9882046 | Vomiting | |
| 98820464 | 9882046 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 98820464 | 9882046 | 1 | 20120410 | 0 | ||
| 98820464 | 9882046 | 2 | 20120426 | 0 | ||
| 98820464 | 9882046 | 3 | 20120510 | 0 | ||
| 98820464 | 9882046 | 4 | 20120503 | 0 | ||
| 98820464 | 9882046 | 5 | 20101130 | 0 | ||
| 98820464 | 9882046 | 6 | 20120301 | 0 | ||
| 98820464 | 9882046 | 7 | 20120224 | 0 | ||
| 98820464 | 9882046 | 8 | 20120224 | 0 | ||
| 98820464 | 9882046 | 9 | 20120221 | 0 | ||
| 98820464 | 9882046 | 10 | 20121003 | 0 | ||
| 98820464 | 9882046 | 11 | 20110913 | 0 |